← Back to Clinical Trials
Recruiting NCT07085026

NCT07085026 Effects of Yoga on Sleep and Stress in the Third Trimester of Pregnancy

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07085026
Status Recruiting
Phase —
Sponsor Istanbul University - Cerrahpasa
Condition Sleep
Study Type INTERVENTIONAL
Enrollment 112 participants
Start Date 2025-08-21
Primary Completion 2026-02-01

Eligibility & Interventions

Sex Female only
Min Age 18 Years
Max Age 35 Years
Study Type INTERVENTIONAL
All Conditions
Interventions
Yoga Intervention

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 112 participants in total. It began in 2025-08-21 with a primary completion date of 2026-02-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Many physiological and psychological changes occur during pregnancy. Sleep and stress are among these changes and can negatively impact the pregnancy process. Yoga can improve sleep quality and stress levels during pregnancy. The purpose of this study was to evaluate the effects of yoga, implemented in the third trimester of pregnancy according to World Health Organization guidelines, on sleep and stress.

Eligibility Criteria

Inclusion Criteria: * Voluntarily agreed to participate in the study, * Aged between 18 and 35 years, * In the third trimester of pregnancy (between 29 and 42 weeks of gestation), * Able to read and write in Turkish, * No prior experience with yoga practice. Exclusion Criteria: * High-risk pregnancy, * In the first or second trimester, * Multiple pregnancy, * Any condition that prevents yoga practice (e.g., restrictions on physical activity), * Previous experience with yoga practice

Contact & Investigator

Central Contact

Gözde GÖZDE Şengün, Undergraduate

✉ gozdeesengun@gmail.com

📞 +905384262803

Principal Investigator

Tülay TÜLAY Yılmaz, Associate Professor

STUDY DIRECTOR

Istanbul University - Cerrahpasa

Frequently Asked Questions

Who can join the NCT07085026 clinical trial?

This trial is open to female participants only, aged 18 Years or older, up to 35 Years, studying Sleep. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07085026 currently recruiting?

Yes, NCT07085026 is actively recruiting participants. Contact the research team at gozdeesengun@gmail.com for enrollment information.

Where is the NCT07085026 trial being conducted?

This trial is being conducted at Istanbul, Turkey (Türkiye).

Who is sponsoring the NCT07085026 clinical trial?

NCT07085026 is sponsored by Istanbul University - Cerrahpasa. The principal investigator is Tülay TÜLAY Yılmaz, Associate Professor at Istanbul University - Cerrahpasa. The trial plans to enroll 112 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology